A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease
Movement Disorders · 2025-12 · 40 (12) · 2732-2745
DOI: 10.1002/mds.70030 ↗Kurz gefasst
Fallbericht in der Zeitschrift Movement Disorders, online erschienen am 04.09.2025. Verfasst von Mohammed Al-Azzani und 24 weiteren Autor:innen. Beteiligte Einrichtung: University Medical Center Göttingen, Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Göttingen, …. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease, Mutation, Missense. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Addenbrooke's Charitable Trust, Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Background
Parkinson's disease (PD) is a complex multifactorial disorder with a genetic component in about 15% of cases. Multiplications and point mutations in SNCA gene, encoding α‐synuclein (aSyn), are linked to rare familial forms of PD.
Objective
Our goal was to assess the clinical presentation and the biological effects of a novel K58N aSyn mutation identified in a patient with PD.
Methods
We describe the clinical presentation associated with the novel mutation, together with genetic testing through whole exome sequencing (WES). Furthermore, we conducted extensive biophysical and cellular assays to assess the functional consequences of this novel variant.
Results
The patient exhibited typical features of sporadic PD with early onset and a benign disease course. WES showed a novel heterozygous missense variant in SNCA (NM_000345.4, c.174G>C; p.K58N). A positive family history of PD was evident, because both a parent and a grandparent had been diagnosed with PD but were deceased. The patient underwent deep brain stimulation surgery 13 years postdiagnosis, showing stable, long‐term improvements in motor symptoms. Biophysical studies demonstrated K58N substitution causes local structural effects, disrupts membrane binding, and enhances aSyn in vitro aggregation. In cellular systems, K58N aSyn produces fewer inclusions per cell and does not form condensates. The variant increases aSyn cytoplasmic distribution and displays aberrant activity‐dependent dynamic serine‐129 phosphorylation.
Conclusions
The clinical presentation associated with the novel K58N aSyn mutation suggests a relatively benign PD course consistent with the phenotypic spectrum of idiopathic PD. Overall, our molecular studies provide novel insight into the biology and pathobiology of aSyn. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University Medical Center Göttingen, Department of Experimental Neurodegeneration, Center for Biostructural Imaging of Neurodegeneration, Göttingen, Germany.
- Department of Neurology, University Medical Center Göttingen, Göttingen, Germany.
- Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
- Institute of Neurogenomics, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
- Institute of Human Genetics, TUM School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Institute for Advanced Study, Technical University of Munich, Garching, Germany.
ORCID-Profile: Mohammed Al-Azzani, Sandrina Weber, Nagendran Ramalingam, Michael Zech, Brit Mollenhauer
Förderung
- NINDS NIH HHS
- Addenbrooke's Charitable Trust
- Deutsche Forschungsgemeinschaft
- Leverhulme Trust
- NIH HHS
- European Joint Programme on Rare Diseases, EJP RD Joint Transnational Call 2022
- Michael J. Fox Foundation for Parkinson's Research
- Else Kröner-Fresenius-Stiftung
Zitieren
APA
Al-Azzani, M., Weber, S., Ramalingam, N., Ramón, M., Shvachiy, L., Mestre, G., Zech, M., Sicking, K., de Opakua, A. I., Jayanthi, V., Amaral, L., Agarwal, A., Chandran, A., Chaves, S. R., Winkelmann, J., Trenkwalder, C., Schwager, M., Pauli, S., Dettmer, U., …, & Outeiro, T. F. (2025). A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease. Movement Disorders, 40(12), 2732-2745. https://doi.org/10.1002/mds.70030
Vancouver
Al-Azzani M, Weber S, Ramalingam N, Ramón M, Shvachiy L, Mestre G, et al. A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease. Movement Disorders. 2025;40(12):2732-2745. doi:10.1002/mds.70030
BibTeX
@article{AlAzzani2025,
author = {Al-Azzani, Mohammed and Weber, Sandrina and Ramalingam, Nagendran and Ramón, Maria and Shvachiy, Liana and Mestre, Gonçalo and Zech, Michael and Sicking, Kevin and de Opakua, Alain Ibáñez and Jayanthi, Vidyashree and Amaral, Leslie and Agarwal, Aishwarya and Chandran, Aswathy and Chaves, Susana R and Winkelmann, Juliane and Trenkwalder, Claudia and Schwager, Maike and Pauli, Silke and Dettmer, Ulf and Fernández, Claudio O and Lautenschläger, Janin and Zweckstetter, Markus and Fernandez-Busnadiego, Ruben and Mollenhauer, Brit and Outeiro, Tiago Fleming},
title = {A Novel α‐Synuclein K58N Missense Variant in a Patient with Parkinson's Disease},
journal = {Movement Disorders},
year = {2025},
volume = {40},
number = {12},
pages = {2732--2745},
doi = {10.1002/mds.70030}
}
EUVIMED